200 related articles for article (PubMed ID: 11564368)
21. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
[TBL] [Abstract][Full Text] [Related]
22. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Wang X; Ding Y; Zhou Z; Hou J; Xu Y; Li J
Pediatr Rheumatol Online J; 2021 Jan; 19(1):6. PubMed ID: 33407621
[TBL] [Abstract][Full Text] [Related]
24. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
25. Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression.
Pachman LM
Rheum Dis Clin North Am; 2002 Aug; 28(3):579-602, vii. PubMed ID: 12380371
[TBL] [Abstract][Full Text] [Related]
26. Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis.
Werth VP; Callen JP; Ang G; Sullivan KE
J Invest Dermatol; 2002 Sep; 119(3):617-20. PubMed ID: 12230503
[TBL] [Abstract][Full Text] [Related]
27. Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.
Huber AM
Paediatr Drugs; 2009; 11(6):361-74. PubMed ID: 19877722
[TBL] [Abstract][Full Text] [Related]
28. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
Mamyrova G; O'Hanlon TP; Sillers L; Malley K; James-Newton L; Parks CG; Cooper GS; Pandey JP; Miller FW; Rider LG;
Arthritis Rheum; 2008 Dec; 58(12):3941-50. PubMed ID: 19035492
[TBL] [Abstract][Full Text] [Related]
29. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Kim NN; Lio PA; Morgan GA; Jarvis JN; Pachman LM
Arch Dermatol; 2011 Jul; 147(7):831-5. PubMed ID: 21422326
[TBL] [Abstract][Full Text] [Related]
30. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
Christen-Zaech S; Seshadri R; Sundberg J; Paller AS; Pachman LM
Arthritis Rheum; 2008 Feb; 58(2):571-6. PubMed ID: 18240225
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.
Kim E; Cook-Mills J; Morgan G; Sredni ST; Pachman LM
Arthritis Rheum; 2012 Nov; 64(11):3809-17. PubMed ID: 22740338
[TBL] [Abstract][Full Text] [Related]
32. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
[TBL] [Abstract][Full Text] [Related]
33. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal peripheral blood lymphocyte subsets correlate with decreased disease activity in juvenile dermatomyositis.
Ernste FC; Crowson CS; de Padilla CL; Hein MS; Reed AM
J Rheumatol; 2013 Jul; 40(7):1200-11. PubMed ID: 23678152
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.
Zhao Y; Fedczyna TO; McVicker V; Caliendo J; Li H; Pachman LM
Clin Immunol; 2007 Nov; 125(2):165-72. PubMed ID: 17704000
[TBL] [Abstract][Full Text] [Related]
36. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.
Pachman LM; Lipton R; Ramsey-Goldman R; Shamiyeh E; Abbott K; Mendez EP; Dyer A; Curdy DM; Vogler L; Reed A; Cawkwell G; Zemel L; Sandborg C; Rivas-Chacon R; Hom C; Ilowite N; Gedalia A; Gitlin J; Borzy M
Arthritis Rheum; 2005 Apr; 53(2):166-72. PubMed ID: 15818654
[TBL] [Abstract][Full Text] [Related]
37. Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study.
Bukhari A; Khojah A; Marin W; Khramtsov A; Khramtsova G; Costin C; Morgan G; Ramesh P; Klein-Gitelman MS; Le Poole IC; Pachman LM
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445728
[TBL] [Abstract][Full Text] [Related]
38. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.
Gitiaux C; De Antonio M; Aouizerate J; Gherardi RK; Guilbert T; Barnerias C; Bodemer C; Brochard-Payet K; Quartier P; Musset L; Chazaud B; Desguerre I; Bader-Meunier B
Rheumatology (Oxford); 2016 Mar; 55(3):470-9. PubMed ID: 26424834
[TBL] [Abstract][Full Text] [Related]
39. Elevated type I IFN signalling directly affects CD8
Huang B; Li H; Jiang Q; Li Y; Jiang Z; Cao H; Wang S; Wang X; Li J; Li G
J Autoimmun; 2024 Jun; 146():103232. PubMed ID: 38692172
[TBL] [Abstract][Full Text] [Related]
40. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.
Ostrowski RA; Sullivan CL; Seshadri R; Morgan GA; Pachman LM
Arthritis Rheum; 2010 May; 62(5):1533-8. PubMed ID: 20213809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
